Diabetes management app Wellthy raised $4 million from Saama Capital

Diabetes management startup Wellthy Therapeutics raised $4.2 million in Pre-Series A from Saama Capital, at an approximate $23 million valuation Wellthy focuses on type 2 diabetes care through a mobile app which lets users log their meals and monitor their blood sugar levels over time. Wealthy’s revenue from increased by 10.4 times from Rs 8.56 Lacs to Rs 89.73 Lacs, on an expenditure of Rs 9.84 crore, a 2.56 times increase and the losses stood at Rs 8.69 crore.

26 views0 comments
  • Amazon Social Icon
  • Facebook Social Icon
  • LinkedIn Social Icon
  • Twitter Social Icon
  • Instagram

© 2021 by StartupNews. Proudly created in India